AAIC 2018: Treating non-cognitive symptoms of individuals with dementia

Written by Jasmine Harris, Future Science Group

New research, presented at the Alzheimer’s Association International Conference (21–26 July, IL, USA), focuses on the treatment of non-cognitive symptoms of individuals with Alzheimer’s disease (AD). Behavioral and psychological symptoms of dementia include: agitation, anxiety, apathy, depression, wandering, hallucinations, insomnia, incontinence and disinhibition, and these often cause the greatest challenges to caregivers and reduction in quality of life. There are currently no US FDA-approved drug treatments for these symptoms associated with AD, and any treatments currently utilized to control the non-cognitive symptoms are approved for other indications and prescribed ‘off-label’. “These under-recognized and undertreated symptoms in people with Alzheimer’s and...

To view the full article, please register now for access

It's completely free